by TaxOps | Oct 12, 2023 | Main Tax Min, Tax Minimization, Tax News
Add value to your private equity deals with research tax credits for innovative portfolio companies. By Mark Dunning and Jamie Overberg Business transactions involving private equity portfolio companies often trigger complex tax considerations across various...
by TaxOps | Jul 26, 2022 | State and Local, Tax News
Jamie Overberg, Partner at TaxOps Minimization, shares insights on R&D expenses and credits with a panel of tax professionals for Bloomberg Tax. By Hogan Humphries, Jamie Overberg, Lawrence Sannicandro, and Jonathan Forman* KPMG LLP,...
by TaxOps | May 27, 2022 | Main Tax Min, Tax Minimization, Tax News
Jamie Overberg, Partner at TaxOps Minimization, suggested that the 2022-2023 priority guidance plan (Notice 2021-22) include guidance that identifies cost categories for research and experimental expenditures under section 174(a). May 12, 2022 Ms. Emily M....
by TaxOps | Sep 4, 2020 | Tax Minimization, Tax News, White Papers
Research and development in the United States never fails to amaze, and neither will the innovation to come in response to COVID-19. By Jamie Overberg, as featured in the ColoradoBiz There’s nothing like a pandemic to spur on discoveries that lead to the types...
by TaxOps | Aug 5, 2020 | Tax Minimization, Tax News, White Papers
Researching a rare disease? Get tax credit for that with the federal Orphan Drug Credit. By Jamie Overberg The orphan drug credit (ODC) is a federal tax credit available to companies working to find cures to rare diseases. It is not widely...
Recent Comments